Pear Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pear Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q4 2022.
  • Pear Therapeutics, Inc. Depreciation for the quarter ending December 31, 2022 was $928K, a 41.2% increase year-over-year.
  • Pear Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2022 was $3.35M, a 98.2% increase year-over-year.
  • Pear Therapeutics, Inc. annual Depreciation for 2022 was $3.35M, a 98.2% increase from 2021.
  • Pear Therapeutics, Inc. annual Depreciation for 2021 was $1.69M, a 343% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $3.35M $928K +$271K +41.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $3.08M $879K +$432K +96.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.64M $817K +$509K +165% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.14M $723K +$446K +161% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.69M $657K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $447K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $308K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $277K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.